Spotlight On Medical & Health: Trial and error
Clinical trials on humans is witnessing great technological advances, but they can be dangerous, as the Te Genero case proved in 2006. With compulsory insurance required, how can insurers manage the risks involved?
Insuring clinical trials, where prototype drugs or medical instruments are tested on humans, can be a minefield. One look at the infamous Te Genero trial back in 2006 shows exactly what can go wrong
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@postonline.co.uk
More on Personal
How an AI-assisted motor claims handler cared for me
Editor’s View: Emma Ann Hughes shares how a recent call to her motor insurer highlighted why humans will always be needed to care for policyholders in their hour of need.
Motor premiums fall for first time in over two years
Car insurance premiums have fallen by 5% during the past three months, according to the latest data from Confused.com.
Aviva’s Storah has ‘big ambitions’ for HNW
Jason Storah, Aviva’s UK & Ireland general insurance CEO, has revealed his “big ambitions” for the high-net-worth business, and teased a potential entry into pet insurance, as the insurer is “always looking” at expansion opportunities in personal lines.
Integration and restructuring costs push RSA to 2023 loss
RSA has reported a £19m pre-tax loss for 2023, despite improving on both its 2022 underwriting and investment performance.
Could Jaguar Land Rover issues derail OEM insurance ambitions?
Following customer concerns over Jaguar Land Rover’s embedded scheme, Tom Luckham contemplates whether the original equipment manufacturer-led car insurance revolution is still a distant dream?
Direct Line’s chief customer officer Kate Syred retires
Direct Line Group’s chief customer officer Kate Syred has retired after more than 20 years at the insurer, Insurance Post can reveal.
Aviva CEO warns home insurance premiums need to go up
After Aviva said the motor insurance market has shown early signs of softening, UK & Ireland general insurance CEO Jason Storah has warned home insurance premiums “still need to go up”.
Foil’s Allchorne on keeping the OIC tariffs in proportion
Trade Voice: Pete Allchorne, president of Forum of Insurance Lawyers and partner at DAC Beachcroft, says now is not the time to increase the OIC tariff amounts.
Most read
- Aviva CEO warns home insurance premiums need to go up
- Integration and restructuring costs push RSA to 2023 loss
- Which urges FCA to take action on premium finance following investigation